{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:10:53Z","timestamp":1787022653365,"version":"build-2736575974"},"reference-count":34,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1517\/14656566.1.3.419","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T19:29:31Z","timestamp":1115234971000},"page":"419-433","source":"Crossref","is-referenced-by-count":2,"title":["Platelet glycoprotein IIb\/IIIa receptor antagonists"],"prefix":"10.1517","volume":"1","author":[{"given":"Ivan P","family":"Casserly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1172\/JCI110973","volume":"72","author":"COLLER BS","year":"1983","journal-title":"J. Clin. Invest."},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V61.1.99.99","volume":"61","author":"COLLER BS","year":"1983","journal-title":"Blood"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.CIR.68.1.139","volume":"68","author":"DE WOOD MA","year":"1983","journal-title":"Circulation"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJM199606063342308","volume":"334","author":"FRENETTE PS","year":"1996","journal-title":"N Engl. J. Med."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/0735-1097(94)90162-7","volume":"24","author":"JANG Y","year":"1994","journal-title":"J. Am. Coll. Cardiol"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","volume":"353","author":"TOPOL EJ","year":"1999","journal-title":"Lancet"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood.V91.8.2645.2645_2645_2657","volume":"91","author":"SHATTIL SJ","year":"1998","journal-title":"Blood"},{"key":"CIT0015","first-page":"3828","volume":"96","author":"COLLER BS","year":"1998","journal-title":"Circulation"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/hj.1999.v138.a100459","volume":"138","author":"KLEIMAN NS","year":"1999","journal-title":"Am. Heart J."},{"key":"CIT0020","first-page":"437","volume":"100","author":"SCARBOROUGH RM","year":"1999","journal-title":"What are the relevant issues concerning their pharmacology and clinical use? Circulation"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1161\/01.CIR.96.11.3860","volume":"96","author":"MASCELLI MA","year":"1997","journal-title":"Circulation"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0002-9149(99)00321-5","volume":"84","author":"KERIAKES DJ","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"THE EPIC INVESTIGATION","year":"1994","journal-title":"[see comments]. N Engl. J. Med."},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","volume":"336","author":"THE EPILOG INVESTIGATORS","year":"1997","journal-title":"N Engl. J. Med."},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","volume":"349","author":"THE CAPTURE STUDY","year":"1997","journal-title":"Lancet"},{"key":"CIT0031","first-page":"1445","volume":"96","author":"THE RESTORE INVESTIGATORS","year":"1997","journal-title":"Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation"},{"key":"CIT0032","first-page":"87","volume":"352","author":"THE EPISTENT INVESTIGATORS","year":"1998","journal-title":"Evaluation of Platelet Ilb\/Illa Inhibitor for Stenting [see comments]. Lancet"},{"key":"CIT0033","first-page":"734","volume":"98","author":"BRENER SJ","year":"1998","journal-title":"Random- ized, placebo-controlled trial of platelet glycoprotein Ilb\/Illa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9149(96)00490-0","volume":"78","author":"TCHENG JE","year":"1996","journal-title":"Am. J. Cardiol"},{"key":"CIT0037","first-page":"2829","volume":"98","author":"KONG DF","year":"1999","journal-title":"MILLER DP ET AL.: Clinical outcomes of therapeutic agents that block the platelet glycoprotein Hb\/IIIa integrin in ischaemic heart disease. Circulation"},{"key":"CIT0039","first-page":"319","volume":"341","author":"LINCOFF AM","year":"1999","journal-title":"Evaluation of Platelet Ilb\/Illa Inhibition in Stenting Investigators. N. Engl. J. Med."},{"key":"CIT0040","first-page":"1951","volume":"99","author":"LINCOFF AM","year":"1999","journal-title":"CALIFF RM ET AL. :Sustainedsuppression of ischemic complications of coronary intervention by platelet GP Ilb\/Illa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP Ilb\/Illa blockade. Circulation"},{"key":"CIT0041","first-page":"2486","volume":"99","author":"FERGUSON JJ","year":"1999","journal-title":"Highlights of thelist Scientific Sessions of the American Heart Associa-tion. Circulation"},{"key":"CIT0042","first-page":"479","volume":"278","author":"TOPOL EJ","year":"1997","journal-title":"EPIC Investi-gator Group. Evaluation of Platelet Ilb\/Illa Inhibition for Prevention of Ischemic Complication [see comments]. JAMA"},{"key":"CIT0043","first-page":"1498","volume":"338","author":"PRISM STUDY INVESTIGATORS","year":"1998","journal-title":"Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators [see comments]. N Engl. J. Med."},{"key":"CIT0045","first-page":"436","volume":"339","author":"THE PURSUIT TRIAL INVESTIGATORS","year":"1998","journal-title":"Platelet Glycoprotein Ilb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy [see comments]. N Engl. J. Med."},{"key":"CIT0047","first-page":"2658","volume":"90","author":"KLEIMAN NS","year":"1994","journal-title":"The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptoki-nase and Tissue Plasminogen Activator for Occluded Coronary Arteries [see comments]. Circulation"},{"key":"CIT0048","first-page":"1923","volume":"91","author":"SIMES RJ","year":"1995","journal-title":"Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators [see comments]. Circulation"},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/0735-1097(94)90163-5","volume":"24","author":"CANNON CP","year":"1994","journal-title":"J. Am. Coll. Cardiol"},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","author":"THE GUSTO INVESTIGATORS","year":"1993","journal-title":"N. Engl. J. Med"},{"key":"CIT0051","first-page":"349","volume":"2","author":"ISIS-","year":"1988","journal-title":"Lancet"},{"key":"CIT0054","first-page":"846","volume":"95","author":"OHMAN EM","year":"1997","journal-title":"Results of a randomized, placebo- controlled, dose-ranging trial. IMPACT-AMI Investigators [see comments]. Circulation"},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0735-1097(98)00474-4","volume":"32","author":"PARADIGM TRIAL","year":"1998","journal-title":"J. Am. Coll. Cardiol"},{"key":"CIT0059","first-page":"932A","volume":"96","author":"CANNON CP","year":"1997","journal-title":"Circulation"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.1.3.419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T02:46:44Z","timestamp":1586227604000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.1.3.419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1517\/14656566.1.3.419"],"URL":"https:\/\/doi.org\/10.1517\/14656566.1.3.419","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}